We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+3.9%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$126M
AUM Growth
-$27.3M
Cap. Flow
-$37.9M
Cap. Flow %
-30.16%
Top 10 Hldgs %
76.77%
Holding
47
New
7
Increased
5
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$7.21M
2
AKRX
Akorn Inc
AKRX
+$4.67M
3
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$3.4M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.12M
5
UNH icon
UnitedHealth
UNH
+$2M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$13.8M
2
AGN
Allergan plc
AGN
+$11.8M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$9.78M
4
CXRX
Concordia International Corp. Common Stock
CXRX
+$6.28M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.52M

Sector Composition

Rank Sector Weight
1 Healthcare 53.99%
2 Consumer Discretionary 13.89%
3 Communication Services 8.45%
4 Financials 5.94%
5 Technology 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$20.4M 16.2%
525,479
-234,900
-31% -$9.78M
AMZN icon
2
Amazon
AMZN
$2.5T
$14.3M 11.38%
400,000
+213,220
+114% +$7.21M
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$10.6M 8.45%
93,000
-38,755
-29% -$4.47M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.4M 8.24%
629,075
-44,000
-7% -$712K
AMZN icon
5
CALL
Amazon
AMZN
$2.5T
$10.3M 8.17%
+3,000
New +$101K
ARLZ
6
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$9.03M 7.18%
2,737,140
+900,765
+49% +$3.4M
BX icon
7
Blackstone
BX
$104B
$7.24M 5.75%
295,009
– –
AKRX
8
DELISTED
Akorn Inc
AKRX
$5.27M 4.19%
184,998
+168,492
+1,021% +$4.67M
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$4.77M 3.79%
444,439
-30,000
-6% -$320K
LGND icon
10
Ligand Pharmaceuticals
LGND
$6.02B
$4.31M 3.43%
57,987
– –
WING icon
11
Wingstop
WING
$3.68B
$3.16M 2.51%
116,057
– –
BSTC
12
DELISTED
BioSpecifics Technologies Corp.
BSTC
$2.9M 2.31%
72,649
– –
JNP
13
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2.3M 1.83%
328,132
– –
QLTI
14
DELISTED
QLT Inc
QLTI
$2.26M 1.8%
1,592,993
– –
BMY icon
15
Bristol-Myers Squibb
BMY
$127B
$2.21M 1.75%
+30,000
New +$2.12M
UNH icon
16
UnitedHealth
UNH
$382B
$2.12M 1.68%
+15,000
New +$2M
INSY
17
DELISTED
Insys Therapeutics, Inc.
INSY
$1.95M 1.55%
150,638
-70,900
-32% -$1.03M
CBM
18
DELISTED
Cambrex Corporation
CBM
$1.82M 1.45%
35,148
– –
ISRG icon
19
Intuitive Surgical
ISRG
$121B
$1.65M 1.31%
+22,500
New +$1.58M
CRM icon
20
Salesforce
CRM
$134B
$1.59M 1.26%
+20,000
New +$1.57M
SGNT
21
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.52M 1.21%
101,630
– –
ASRT
22
DELISTED
Assertio
ASRT
$1.14M 0.9%
965
-1,000
-51% -$1.09M
JNJ icon
23
Johnson & Johnson
JNJ
$635B
$728K 0.58%
+6,000
New +$682K
ADVM
24
DELISTED
Adverum Biotechnologies
ADVM
$600K 0.48%
18,992
– –
MLM icon
25
Martin Marietta Materials
MLM
$33.6B
$576K 0.46%
+3,000
New +$537K
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return

JW Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, JW Asset Management held 47 positions worth $126M, down 18% from $153M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

JW Asset Management withdrew a net $37.9M in Q2 2016, closing 9 positions and reducing 7 holdings. Its most notable exit was Starbucks, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 61% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in Bristol-Myers Squibb worth $2.21M.

  • JW Asset Management's largest Q2 2016 buy was Bristol-Myers Squibb: 30,000 shares worth $2.21M.
  • JW Asset Management added most to Amazon in Q2 2016, an estimated $7.21M increase.
  • JW Asset Management's biggest Q2 2016 reduction was Eagle Pharmaceuticals, Inc., cutting an estimated $9.78M.
  • JW Asset Management fully exited Starbucks in Q2 2016, selling an estimated $13.8M.
  • JW Asset Management's ten largest holdings make up 77% of its $126M portfolio in Q2 2016.
  • JW Asset Management opened 7 new positions and closed 9 in Q2 2016.
  • JW Asset Management's portfolio value fell 18% quarter-over-quarter to $126M.

Based on JW Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.